Global Nuclear Medicine Market Report: The global Nuclear Medicine market is valued at 4590 million US$ in 2017 and will reach 7580 million US$ by the end of 2025, growing at a CAGR of 7.4% during 2018-2025.

Global Nuclear Medicine Market Research Report 2018

 

This report studies the global Nuclear Medicine market status and forecast, categorizes the global Nuclear Medicine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

 

Nuclear Medicine,or Radiopharmaceuticals, are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The global average price of Nuclear Medicine is in the decreasing trend, from 41.6 USD/Dose in 2011 to 39.5 USD/Dose in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 in 2015 is about 51.60%, and the proportion is stable from 2011 to 2015.

Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share in 2015 is 61.23%. The trend of Diagnostic is decreasing.

The global Nuclear Medicine market is valued at 4590 million US$ in 2017 and will reach 7580 million US$ by the end of 2025, growing at a CAGR of 7.4% during 2018-2025.

 

Click to request a sample: https://www.qyresearch.com/sample-form/form/320279/global-nuclear-medicine-market

 

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

GE Healthcare

Bracco Imaging

Mallinckrodt

Lantheus Medical Imaging

Bayer

Triad Isotopes

Nordion

Jubilant Pharma

Eli Lilly

SIEMENS

China Isotope & Radiation

Dongcheng

 

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Nuclear Medicine in these regions, from 2013 to 2025, covering

North America (United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific)

Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)

Central & South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Saudi Arabia,Turkey, Rest of Middle East & Africa)

 

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Tc-99

I-123/131

In-111

Xe-133

Th-201

Ga-67

Other

 

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

Diagnostic

Therapeutic

 

The study objectives of this report are:

To analyze and study the global Nuclear Medicine sales, value, status (2013-2017) and forecast (2018-2025).

Focuses on the key Nuclear Medicine manufacturers, to study the sales, value, market share and development plans in future.

Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

To define, describe and forecast the market by type, application and region.

To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

To identify significant trends and factors driving or inhibiting the market growth.

To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

 

In this study, the years considered to estimate the market size of Nuclear Medicine are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

 

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

Key Stakeholders

Nuclear Medicine Manufacturers

Nuclear Medicine Distributors/Traders/Wholesalers

Nuclear Medicine Subcomponent Manufacturers

Industry Association

Downstream Vendors

 

Available Customizations

With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Nuclear Medicine market, by end-use.

Detailed analysis and profiles of additional market players.

 

Read the full report : https://www.qyresearch.com/index/detail/320279/global-nuclear-medicine-market

 

Related Reports:

US Nuclear Medicine Market Report 2018

Europe Nuclear Medicine Market Report 2018

India Nuclear Medicine Market Report 2018

China Nuclear Medicine Market Report 2018

Korea Nuclear Medicine Market Report 2018

Japan Nuclear Medicine Market Report 2018

 

Note:We also offer

Germany/Australia/Brazil/Russia/Indonesia/ Malaysia/Saudi Arabia/Middle East/Asia/Asia-Pacific/Southeast Asia/North America/ Latin America/South America/AMER/EMEA/Africa etc Countries/Regions and Sales/Industry Versions Respectively

 

Request for more information:

sales@qyresearchglobal.com | hebe@qyresearchglobal.com

 

About Us: QYResearch established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

 

 

Contact US

QY Research, INC.

Room 2905, Vili International, 167 Linhe West Road, Tianhe District,

Guangzhou, Guangdong Province, China

CN: +86-20-22093278

Email – sales@qyrsearchglobal.com

Web – www.qyresearch.com

About QYResearch

QYResearch, established in 2007, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base &seminar services.

View all posts by QYResearch →